With increasing generic penetration and also mounting fierce competition, pharmaceutical companies are under severe pressure to update their portfolio regularly with differentiated and innovative products.
ACPC has partnered with some boutique contract research organisations (CROs) who specialise in their specific domains.
We are focused on offering products with value addition:
- Molecules which are challenging to develop or handle – Light/Humidity/Temperature sensitive, irritants, cytotoxic etc.
- Modified Release products – Matrix, Osmotic, Layered, Tab in Tab etc.
- OTC Products with differentiation – Rapid or Sustained release, combinations, new dosage forms etc.
Currently we are capable of developing products in Oral solids, Oral Liquids and Injectables.